Research on Health Economics and the Pharmaceutical Industry
The research activity of IDEI on Health Economics and the Pharmaceutical Industry concerns the following general topics of research :
-
Economics and Value of Health:
Determinants of health, value of health, including the consequences of better health for economic growth and patient welfare, and health expenses as investment vs. consumption.
-
Health System Reform, with a special emphasis on European health systems:
Potential for market oriented solutions to provide affordable and sustainable health care. Consumer behavior; health related expenditures; consequences of insurance.
-
Industrial organization of the drug industry:
Drivers of innovation in the health care industry and, more specifically, in the drug industry. Intellectual property policy (including patents) and the link to innovation
-
Industry Regulation and Consequences:
Regulation and reimbursement of new products. Impact of advertising and marketing restrictions on patients and doctors
Participants:
Claude Crampes,
Helmuth Cremer,
Jacques Crémer,
Pierre Dubois,
Frédérique Fève,
Jean-Pierre Florens,
Christian Gollier,
Bruno Jullien,
Margaret Kyle,
Jean-Marie Lozachmeur,
Patrick Rey,
Jean-Charles Rochet,
Paul Seabright,
Nicolas Treich and
Étienne de Villemeur
Project's Documents and Links: